Glimepiride + Pioglitazone
Composition
This Formulation contains Glimepiride and Pioglitazone as a active pharmaceutical ingrediant
Indications
Used for the treatment of type 2 diabetes mellitus
Side effects
Common side effects include hypoglycemia,weight gain, edema, and dizziness.
Precautions
Cautiosly used in the patients having heart disease.
Contraindications
Contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, renal or hepatic impairment.
Dosage and administration
2-30 mg once in a day, As directed by physician
Countries
Worldwide
Available Forms
Tablets